How to take crizotinib

Crizotinib is a targeted drug mainly used to treat patients with non-small cell lung cancer (NSCLC) with ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangement. It prevents the growth and spread of cancer cells by inhibiting the activity of ALK and ROS1 kinases. Correct dosing is crucial to maximizing drug efficacy. The following will introduce the dosing method of crizotinib.

Dosage and administration of crizotinib

Crizotinib is usually taken as an oral tablet. Specific dosage methods include:

1.Recommended dosage:

The standard dose of crizotinib is 250 mg twice daily (i.e. 500 mg /day). Patients should take the medication at the prescribed dose.

If adverse reactions occur, your doctor may adjust the dose. Common adjustments include dose reduction or dosing intervals, which are determined based on the patient's tolerance and the severity of adverse reactions.

2.How to take:

Crizotinib is taken by mouth and can be taken before or after a meal.

When taking the medicine, swallow the tablets with enough water and avoid chewing or crushing the tablets. This facilitates optimal absorption of the medication.

3.Medication cycle:

Treatment with crizotinib is usually continued long-term until disease progression or intolerable side effects occur. Patients should be followed up regularly to evaluate drug efficacy and side effects.

4.Handling of missed doses:

If a dose is missed, the patient should take the dose as soon as he remembers, unless the next dose is near. At this time, patients should not supplement with a double dose.

5.Indications for discontinuation:

If the patient experiences serious adverse reactions, or if the drug is confirmed to be ineffective through clinical examination, the drug may need to be discontinued or the treatment plan may need to be changed. Discontinuation of medication should be done under the guidance of a doctor.

Precautions during medication

1.Monitor side effects:

During treatment with crizotinib, patients need to undergo regular monitoring, including liver function, heart function (QT interval monitoring), eye examination, etc., to avoid possible side effects.

2.Drug interactions:

Crizotinib may interact with other drugs, especially drugs that affect theCYP3A4 enzyme system. Patients should inform their doctors about all medications they are taking, including prescription, over-the-counter, and herbal medicines.

3.Liver function:

Crizotinib may cause liver damage. Patients need to monitor liver function during use. If abnormalities occur, the dose should be adjusted or the drug discontinued in a timely manner.

4.QTInterval prolongation:

Crizotinib may cause QT interval prolongation and increase the risk of arrhythmia. Therefore, patients need to undergo regular electrocardiogram (ECG) examinations, especially those with a history of heart disease.

5.Pregnant and breastfeeding women:

Crizotinib is not recommended during pregnancy and breastfeeding because of the potential for harm to the fetus or infant. Contraception is needed while using this medicine.

Common side effects and management

Patients taking crizotinib may experience some common side effects, such as gastrointestinal discomfort, visual problems (such as blurred vision), fatigue, abnormal liver function, etc. If patients experience uncomfortable symptoms, they should inform their doctor in time. Depending on the severity of the side effects, your doctor may adjust the dose or recommend symptomatic treatment.

Crizotinib is a targeted drug used to treat non-small cell lung cancer with ALK or ROS1 gene rearrangement. Proper medication use includes taking the medication on time and in the right amount, monitoring side effects, and maintaining regular follow-up visits with your doctor. Patients need to use crizotinib under the guidance of a doctor and undergo necessary examinations and evaluations regularly to ensure the effectiveness and safety of the treatment.